CXCL12 and cervical cancer: Exogenous treatment with recombinant CXCL12 inhibited metastasis-promoting cell migration, cell invasion, and anchorage-independent cell growth events in cervical cancer cell lines (HeLa, SiHa and C-33A) [15].